Showing results (1-10 of 109) with videos related to
Sort By:
Pageof 11
Neurologia I Neurochirurgia Polska|March 28, 2019
Vitamin D as an immune modulator in multiple sclerosisHalina Bartosik-Psujek, Marek PsujekAnnales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina|September 9, 2005
Rare first symptoms of multiple sclerosisHalina Bartosik-Psujek, Marek Psujek, Zbigniew StelmasiakMultiple Sclerosis and Related Disorders|September 30, 2018
Severe disease exacerbation in a patient with neuromyelitis optica spectrum disorder during treatment with dimethyl fumarateMalgorzata Popiel, Marek Psujek, Halina Bartosik-PsujekUpsala Journal of Medical Sciences|May 5, 2012
Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophyJacek Jaworski, Marek Psujek, Marzena Janczarek, et al.Neurologia I Neurochirurgia Polska|August 21, 2002
[Axonal damage in multiple sclerosis]Halina Bartosik-Psujek, Zbigniew StelmasiakNeurologia I Neurochirurgia Polska|March 30, 2004
[The formation and significance of antibodies to interferon beta during immunomodulating treatment of multiple sclerosis]Halina Bartosik-Psujek, Zbigniew StelmasiakEuropean Neurology|November 20, 2004
Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapseHalina Bartosik-Psujek, Zbigniew StelmasiakNeurologia I Neurochirurgia Polska|November 15, 2006
[Multiple sclerosis--difficult answers to easy questions]Halina Bartosik-Psujek, Zbigniew StelmasiakNeurologia I Neurochirurgia Polska|December 19, 2023
Clinical and radiological consequences of delayed therapy escalation in patients with relapsing-remitting multiple sclerosisMałgorzata Popiel, Halina Bartosik-PsujekClinical Neurology and Neurosurgery|December 14, 2005
The interleukin-10 levels as a potential indicator of positive response to interferon beta treatment of multiple sclerosis patientsHalina Bartosik-Psujek, Zbigniew StelmasiakPageof 11